Inhibition of green tea polyphenol EGCG((−)-epigallocatechin-3-gallate) on the proliferation of gastric cancer cells by suppressing canonical wnt/β-catenin signalling pathway

International Journal of Food Sciences and Nutrition

Volumn 67, Issue 7, 2016, Pages 818-827

  Yang, Chenggang ^a   Du, Wenfeng ^a   Yang, Daogui ^a  

^a LIAOCHENG PEOPLE'S HOSPITAL   (China)

Author keywords

Epigallocatechin 3 gallate; gastric carcinoma; proliferation; Wnt catenin signalling

Indexed keywords

ANTINEOPLASTIC AGENT; BETA CATENIN; CATECHIN; EPIGALLOCATECHIN GALLATE; TEA;

ANALOGS AND DERIVATIVES; ANIMAL; APOPTOSIS; CELL CYCLE CHECKPOINT; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECTS; DRUG SCREENING; GENETICS; HUMAN; MALE; METABOLISM; MOUSE; NUDE MOUSE; PATHOLOGY; SIGNAL TRANSDUCTION; STOMACH TUMOR; TEA; TUMOR CELL LINE; WNT SIGNALING PATHWAY;

ANIMALS; ANTICARCINOGENIC AGENTS; APOPTOSIS; BETA CATENIN; CATECHIN; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; MALE; MICE; MICE, NUDE; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; TEA; WNT SIGNALING PATHWAY; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84976306100     PISSN: 09637486     EISSN: 14653478     Source Type: Journal    
DOI: 10.1080/09637486.2016.1198892     Document Type: Article

References (37)

1. S.K.Bhatti, J.H.O’keefe, C.J.Lavie 2013. Coffee and tea:perks for health and longevity? Curr Opin Clin Nutrit Metab Care. 16:688–697.
2. X.F.Chen, J.Qian, D.Pei, C.Zhou, O.D.Roe, F.Zhu, S.H.He, Y.Y.Qian, Y.Zhou, J.Xu,. 2016. Prognostic value of perioperative leukocyte count in resectable gastric cancer. World J Gastroenterol. 22:2818–2827.
3. W.M.Clements, J.Wang, A.Sarnaik, O.J.Kim, J.Macdonald, C.Fenoglio-Preiser, J.Groden, A.M.Lowy 2002. beta-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer. Cancer Res. 62:3503–3506.
4. H.Clevers, R.Nusse 2012. Wnt/β-catenin signaling and disease. Cell. 149:1192–1205.
5. V.Crespy, G.Williamson 2004. A review of the health effects of green tea catechins in in vivo animal models. J Nutr. 134:3431S–3440S.
6. J.Czyzewska, K.Guzinska-Ustymowicz, M.Ustymowicz, A.Pryczynicz, A.Kemona 2010. The expression of E-cadherin-catenin complex in patients with advanced gastric cancer:role in formation of metastasis. Folia Histochem Cytobiol. 48:37–45.
7. W.M.Dashwood, O.Carter, M.Al-Fageeh, Q.Li, R.H.Dashwood 2005. Lysosomal trafficking of beta-catenin induced by the tea polyphenol epigallocatechin-3-gallate. Mutat Res. 591:161–172.
8. N.R.Gough 2012. Focus issue:Wnt and β-catenin signaling in development and disease. Sci Signal. 5:eg2.
9. J.Guo, Z.Fu, J.Wei, W.Lu, J.Feng, S.Zhang 2015. PRRX1 promotes epithelial-mesenchymal transition through the Wnt/β-catenin pathway in gastric cancer. Med Oncol. 32:393.
10. J.Gwak, S.J.Jung, D.I.Kang, E.Y.Kim, D.E.Kim, Y.H.Chung, J.G.Shin, S.Oh 2009. Stimulation of protein kinase C-alpha suppresses colon cancer cell proliferation by down-regulation of beta-catenin. J Cell Mol Med. 13:2171–2180.
11. Y.M.Han, J.M.Park, M.Jeong, J.H.Yoo, W.H.Kim, S.P.Shin, W.J.Ko, K.B.Hahm 2015. Dietary, non-microbial intervention to prevent Helicobacter pylori-associated gastric diseases. Ann Transl Med. 3:122.
12. S.M.Henning, P.Wang, C.L.Carpenter, D.Heber 2013. Epigenetic effects of green tea polyphenols in cancer. Epigenomics. 5:729–741.
13. A.Jemal, F.Bray, M.M.Center, J.Ferlay, E.Ward, D.Forman 2011. Global cancer statistics. CA Cancer J Clin. 61:69–90.
14. M.Jeong, J.M.Park, Y.M.Han, N.Kangwan, S.O.Kwon, B.N.Kim, W.H.Kim, K.B.Hahm 2016. Dietary intervention of artemisia and green tea extracts to rejuvenate Helicobacter pylori-associated chronic atrophic gastritis and to prevent tumorigenesis. Helicobacter. 21:40–59.
15. S.Jia, J.Cai 2016. Update on biomarkers in development of anti-angiogenic drugs in gastric cancer. Anticancer Res. 36:1111–1118.
16. J.Kim, X.Zhang, K.M.Rieger-Christ, I.C.Summerhayes, D.E.Wazer, K.E.Paulson, A.S.Yee 2006. Suppression of Wnt signaling by the green tea compound (-)-epigallocatechin 3-gallate (EGCG) in invasive breast cancer cells. Requirement of the transcriptional repressor HBP1. J Biol Chem. 281:10865–10875.
17. W.Koizumi, H.Narahara, T.Hara, A.Takagane, T.Akiya, M.Takagi, K.Miyashita, T.Nishizaki, O.Kobayashi, W.Takiyama,. 2008. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial):a phase III trial. Lancet Oncol. 9:215–221.
18. C.Y.Logan, R.Nusse 2004. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol. 20:781–810.
19. R.Nusse 2005. Wnt signaling in disease and in development. Cell Res. 15:28–32.
20. A.B.Ochoa-Hernandez, C.I.Juarez-Vazquez, M.A.Rosales-Reynoso, P.Barros-Nunez 2012. WNT-beta-catenin signaling pathway and its relationship with cancer. Cir Cir. 80:389–398.
21. A.A.Ogunleye, F.Xue, K.B.Michels 2010. Green tea consumption and breast cancer risk or recurrence:a meta-analysis. Breast Cancer Res Treat. 119:477–484.
22. S.Oh, J.Gwak, S.Park, C.S.Yang 2014. Green tea polyphenol EGCG suppresses Wnt/β-catenin signaling by promoting GSK-3β- and PP2A-independent β-catenin phosphorylation/degradation. Biofactors. 40:586–595.
23. K.F.Pan, W.G.Liu, L.Zhang, W.C.You, Y.Y.Lu 2008. Mutations in components of the Wnt signaling pathway in gastric cancer. World J Gastroenterol. 14:1570–1574.
24. R.Patel, A.Ingle, G.B.Maru 2008. Polymeric black tea polyphenols inhibit 1,2-dimethylhydrazine induced colorectal carcinogenesis by inhibiting cell proliferation via Wnt/beta-catenin pathway. Toxicol Appl Pharmacol. 227:136–146.
25. P.Polakis 2012. Wnt signaling in cancer. Cold Spring Harb Perspect Biol. 4:1–13.
26. R.Rahman, A.W.Asombang, J.A.Ibdah 2014. Characteristics of gastric cancer in Asia. World J Gastroenterol. 20:4483–4490.
27. M.Sasako, S.Sakuramoto, H.Katai, T.Kinoshita, H.Furukawa, T.Yamaguchi, A.Nashimoto, M.Fujii, T.Nakajima, Y.Ohashi 2011. Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J Clin Oncol. 29:4387–4393.
28. M.Sereno, J.De Castro, P.Cejas, M.A.Garcia-Cabezas, C.Belda, E.Casado, J.Feliu, C.Gómez, M.López, M.G.Barón 2012. Expression profile as predictor of relapse after adjuvant treatment in gastric cancer. J Gastrointest Cancer. 43:181–189.
29. V.Sherwood 2015. WNT signaling:an emerging mediator of cancer cell metabolism? Mol Cell Biol. 35:2–10.
30. Y.Shirakami, M.Shimizu, H.Moriwaki 2012. Cancer chemoprevention with green tea catechins:from bench to bed. Curr Drug Targets. 13:1842–1857.
31. B.N.Singh, S.Shankar, R.K.Srivastava 2011. Green tea catechin, epigallocatechin-3-gallate (EGCG):mechanisms, perspectives and clinical applications. Biochem Pharmacol. 82:1807–1821.
32. K.Sugano 2015. Screening of gastric cancer in Asia. Best Pract Res Clin Gastroenterol. 29:895–905.
33. A.Wodarz, R.Nusse 1998. Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol. 14:59–88.
34. C.S.Yang, H.Wang 2011a. Mechanistic issues concerning cancer prevention by tea catechins. Mol Nutr Food Res. 55:819–831.
35. C.S.Yang, H.Wang, G.X.Li, Z.Yang, F.Guan, H.Jin 2011b. Cancer prevention by tea:evidence from laboratory studies. Pharmacol Res. 64:113–122.
36. H.Zhang, Y.Xue 2008. Wnt pathway is involved in advanced gastric carcinoma. Hepatogastroenterology. 55:1126–1130.
37. Y.Zou, P.Salinas 2014. Introduction:Wnt signaling mechanisms in development and disease. Dev Neurobiol. 74:757–758.